Table 4: ACE inhibitor questionnaire.
Characteristics |
No. of
patients (N = 111) |
Reported side effects |
72 (64.9%) |
Reported dry cough |
68 (61.3%) |
Reported throat clearing |
61 (55%) |
Reported dry throat |
59 (53.2%) |
Presence of symptoms after
discontinuation of ACE inhibitor |
11 (9.9%) |
Still use ACE inhibitor |
38 (34.2%) |
Switched to ARB |
69 (62.2%) |
Data are expressed as
number of patients (percentage). ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin
Receptor Blocker.